Cardiovascular Diseases Clinical Trial
To validate two models which categorized patients with syncope into high and low risk for either sudden death or diagnostic arrhythmias based on data available from the initial history, physical examination, and electrocardiogram.
BACKGROUND:
Syncope is a common medical problem with up to 30 percent of normal individuals reporting
one or more syncopal episodes. Thus, physicians of all specialties are frequently confronted
by patients with syncope. The spectrum of diseases which may cause syncope is broad, ranging
from common benign problems to severe life-threatening disorders. Because of the complexity
of the clinical situation when an obvious cause for syncope is not found, patients may be
subjected to a significant period of hospitalization and a large number of diagnostic tests.
Retrospective and prospective studies have shown that many diagnostic tests are frequently
employed but are infrequently diagnostic of a cause of syncope. Thus, studies have shown
that when a cause is established or suggested, the majority of diagnoses are assigned based
on initial history and physical examination. An initial electrocardiogram is helpful in
assigning a cause of syncope in only approximately five percent of additional patients. In a
prior study prolonged electrocardiographic monitoring was helpful in assigning a cause of
syncope in approximately fifteen percent of patients. Other studies of prolonged
electrocardiographic monitoring in patients with syncope reveal that arrhythmias as a
potential cause of syncope are found in eleven to sixty-four percent of patients. Diagnostic
procedures such as EEG, head CT scan, brain scan, cerebral angiography, echocardiography,
and cardiac catheterization rarely establish a cause of syncope but are useful when employed
selectively for diagnosis of specific etiologies of syncope.
These studies of diagnostic evaluation of syncope, therefore, clearly indicate that there is
a subgroup of patients with syncope who have arrhythmias as a cause of their syncope which
were not apparent from initial history, physical examination, and EKG. Therefore, prolonged
electrocardiographic monitoring has assumed a central role in the diagnostic evaluation of
this group of patients for detection of arrhythmias. Because of the prognostic and
therapeutic importance of arrhythmias causing syncope, it is important to identify patients
who are likely to have arrhythmias from the data available at presentation. There were no
studies prior to 1987 attempting to identify such patients at presentation. The predictors
of diagnostic arrhythmias at presentation may be helpful for four reasons. First, the
variables suggesting high likelihood of arrhythmias may provide a basis for decisions
regarding the need for hospital admission. Secondly, predictors of diagnostic arrhythmias
may identify patients who may need to be monitored immediately as opposed to electively.
Thirdly, patients who have predictors of diagnostic arrhythmias may be more appropriate
candidates for invasive diagnostic testing such as intracardiac electrophysiologic studies.
Fourthly, since patients with arrhythmias are at high risk of sudden death, these predictors
may identify an appropriate subset of patients for further studies involving therapeutic
interventions. Since many patients with syncope have multiple risk factors for sudden death,
the development of a multifactorial model to more effectively and expeditiously predict the
degree of risk of sudden death may be important in the management of patients with syncope
after initial presentation.
DESIGN NARRATIVE:
Two models were validated in this longitudinal study including one which predicted sudden
death and one which predicted diagnostic arrhythmias on monitoring. The model for prediction
of sudden death was developed in patients in whom a cause of syncope was not established by
initial history and physical examination. The predictors in this model included a history of
diabetes mellitus, renal insufficiency, left ventricular hypertrophy, left bundle branch
block, and left axis deviation. The model of predictors of diagnostic arrhythmias was
developed in patients in whom a cause of syncope was not established from initial history,
physical examination, or EKG and included a history of ventricular tachycardia and an
abnormal EKG by specific criteria.
Patients with syncope were accrued from the emergency room, the inpatient services and the
ambulatory clinics of the Presbyterian University Hospital of Pittsburgh. All patients
underwent a basic standardized evaluation consisting of a history, physical examination,
baseline laboratory tests, electrocardiogram, prolonged electrocardiographic monitoring, and
special diagnostic tests as necessary. Diagnosis of a cause of syncope was assigned by
standardized criteria. Follow-up information regarding sudden death and mortality was
obtained at three-month intervals until the end of the study. Causes of death were assigned
in a standardized manner.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|